Earnings Feed
Start Free
Home/Filings/4/0001209191-08-043637
4//SEC Filing

Herrera Malaga Adolfo 4

Accession 0001209191-08-043637

CIK 0000821616other
View on SEC.govCompany Profile

Filed

Jul 23, 8:00 PM ET

Accepted

Jul 24, 5:16 PM ET

Size

53.9 KB

Accession

0001209191-08-043637

Insider Transaction Report

Form 4
Period: 2008-07-22
BENTLEY PHARMACEUTICALS INCBNT
Herrera Malaga Adolfo
Other
Transactions
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−16,335→ 0 total
    Exercise: $7.39From: 2004-01-01Exp: 2013-01-01→ Common Stock, $0.02 par value (16,335 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−40,837→ 0 total
    Exercise: $12.21From: 2005-01-01Exp: 2014-01-01→ Common Stock, $0.02 par value (40,837 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−27,225→ 0 total
    Exercise: $5.39From: 2001-01-03Exp: 2010-01-03→ Common Stock, $0.02 par value (27,225 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−15,718→ 0 total
    Exercise: $10.81From: 2007-05-23Exp: 2016-05-23→ Common Stock, $0.02 par value (15,718 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−18,150→ 0 total
    Exercise: $10.99From: 2008-05-23Exp: 2017-05-23→ Common Stock, $0.02 par value (18,150 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−36,300→ 0 total
    Exercise: $10.99From: 2008-07-22Exp: 2017-05-23→ Common Stock, $0.02 par value (36,300 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−40,838→ 0 total
    Exercise: $12.21From: 2006-01-01Exp: 2014-01-01→ Common Stock, $0.02 par value (40,838 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2008-07-22−11,978→ 0 total
    From: 2008-07-22→ Common Stock, $0.02 par value (11,978 underlying)
  • Disposition to Issuer

    Common Stock, $0.02 par value

    2008-07-22$14.82/sh−31,000$459,312→ 0 total
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−25,410→ 0 total
    Exercise: $6.89From: 2006-03-30Exp: 2015-03-30→ Common Stock, $0.02 par value (25,410 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2008-07-22−54,450→ 0 total
    Exercise: $5.51From: 2002-05-09Exp: 2011-05-09→ Common Stock, $0.02 par value (54,450 underlying)
Footnotes (22)
  • [F1]Disposed of in connection with the merger of Beryllium Merger Corporation ("Acquisition Sub") with and into Bentley Pharmaceuticals, Inc. ("Bentley"), effective July 22, 2008 (the "Effective Time"), (the "Merger"), pursuant to the Agreement and Plan of Merger, dated as of March 31, 2008, by and among Bentley, Teva Pharmaceutical Industries, Ltd. and Acquisition Sub (the "Merger Agreement"). In connection with the Merger, each share of Common Stock listed in Table I was exchanged for the right to receive $14.8165, per share in cash.
  • [F10]This option was cancelled in the Merger in exchange for a cash payment $158,629.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F11]This option was cancelled in the Merger in exchange for a cash payment $91,427.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F12]This option was cancelled in the Merger in exchange for a cash payment $91,427.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F13]This option was cancelled in the Merger in exchange for a cash payment $62,937.17, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F14]This option was cancelled in the Merger in exchange for a cash payment $62,937.17, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F15]Pursuant to the terms of the Merger Agreement, all options, whether or not exercisable or vested at the Effective Time, became, as of the Effective Time fully vested and exercisable.
  • [F16]This option was cancelled in the Merger in exchange for a cash payment $62,925.40, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F17]This option was cancelled in the Merger in exchange for a cash payment $69,510.79, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F18]This option was cancelled in the Merger in exchange for a cash payment $138,997.64, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F19]This option was cancelled in the Merger in exchange for a cash payment $106,311.41, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F2]This option was cancelled in the Merger in exchange for a cash payment $506,758.43, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F20]This option was cancelled in the Merger in exchange for a cash payment $106,326.23, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F21]In connection with the Merger, each Restricted Stock Unit was converted into the right to receive $14.8165 per share in cash.
  • [F22]Restricted Stock Units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Pursuant to the terms of the Merger Agreement, all restricted stock units, whether or not vested at the Effective Time, became, as of the Effective Time fully vested.
  • [F3]This option was cancelled in the Merger in exchange for a cash payment $256,504.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F4]This option was cancelled in the Merger in exchange for a cash payment $201,489.77, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F5]This option was cancelled in the Merger in exchange for a cash payment $201,489.77, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F6]This option was cancelled in the Merger in exchange for a cash payment $201,482.27, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F7]This option was cancelled in the Merger in exchange for a cash payment $121,277.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F8]This option was cancelled in the Merger in exchange for a cash payment $121,277.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
  • [F9]This option was cancelled in the Merger in exchange for a cash payment $158,629.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.

Documents

1 file

Issuer

BENTLEY PHARMACEUTICALS INC

CIK 0000821616

→
Entity typeother

Related Parties

1
  • filerCIK 0001311959

Filing Metadata

Form type
4
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:16 PM ET
Size
53.9 KB
View on SEC.gov